HAVCR2 and neoplasm: It has been reported that M2 macrophages highly expressed Galectin-9 [35, 36], and Galectin-9 could also polarize macrophages toward the M2 phenotype, further inhibiting the anti-tumor function of T lymphocytes through TIM3/Galectin-9 pathway [27, 37, 38].